Quality & complianceOfficial

Gabapentin Orion 600 mg supply problem in Denmark expected to run into early 2027

🇩🇰 DKMA · Thu 19 Nov 2026

The Danish Medicines Agency lists a supply difficulty for Orion Pharma's 600 mg gabapentin tablets, attributed to increased sales and demand, expected from August 2026 to early February 2027.

The Danish Medicines Agency (DKMA) has published a supply notice for Gabapentin "Orion" 600 mg film-coated tablets, marketed by Orion Pharma A/S. The notice, dated 19 November 2026, says there are current problems with supply of the product.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: DKMA ↗

Article written by VigiEye from the official source (DKMA). AI-assisted; check the source before acting.